McCourt Marion 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 9, 2025
Insider Transaction Report
Form 4
McCourt Marion
SVP Commercial
Transactions
- Award
Common Stock
2025-12-05+2,476→ 16,706 total - Tax Payment
Common Stock
2025-12-08$712.94/sh−1,336$952,488→ 15,370 total - Award
Non-Qualified Stock Option (right to buy)
2025-12-05+12,210→ 12,210 totalExercise: $726.71Exp: 2035-12-05→ Common Stock (12,210 underlying)
Holdings
- 197(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.